CAR T cell combination therapies to treat cancer
Cancer Cell · 2024-08 · 42 (8) · 1319-1325
DOI: 10.1016/j.ccell.2024.07.002 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Cell, 2024-08. Verfasst von Ugur Uslu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA; Parker Institute for Cancer…. Hauptthemen laut MEDLINE: Immunotherapy, Adoptive, Neoplasms, Receptors, Chimeric Antigen. Die Arbeit wurde bisher 140-mal zitiert (Crossref) und nennt 15 Literaturangaben. Gefördert von: National Institutes of Health, National Cancer Institute, Parker Institute for Cancer Immunotherapy.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA; Parker Institute for Cancer Immunotherapy at University of Pennsylvania, Philadelphia, PA 19104,…
Förderung
- National Institutes of Health
- National Cancer Institute
- Parker Institute for Cancer Immunotherapy
- Essity Germany
- Deutsche Krebshilfe
- Nihon Kohden America
Zitieren
APA
Uslu, U., Castelli, S., & June, C. H. (2024). CAR T cell combination therapies to treat cancer. Cancer Cell, 42(8), 1319-1325. https://doi.org/10.1016/j.ccell.2024.07.002
Vancouver
Uslu U, Castelli S, June CH. CAR T cell combination therapies to treat cancer. Cancer Cell. 2024;42(8):1319-1325. doi:10.1016/j.ccell.2024.07.002
BibTeX
@article{Uslu2024,
author = {Uslu, Ugur and Castelli, Sofia and June, Carl H},
title = {CAR T cell combination therapies to treat cancer},
journal = {Cancer Cell},
year = {2024},
volume = {42},
number = {8},
pages = {1319--1325},
doi = {10.1016/j.ccell.2024.07.002}
}
EUVIMED